Detalles de la búsqueda
1.
Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat.
Int J Mol Sci
; 22(8)2021 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33919847
2.
A flow cytometry-based assay to determine the ability of anti-Streptococcus pyogenes antibodies to mediate monocytic phagocytosis in human sera.
J Immunol Methods
; 528: 113652, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458312
3.
Testing S. sonnei GMMA with and without Aluminium Salt-Based Adjuvants in Animal Models.
Pharmaceutics
; 16(4)2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675229
4.
Development and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human sera.
J Immunol Methods
; 526: 113618, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237697
5.
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
EBioMedicine
; 104: 105153, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805853
6.
Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella-specific antibodies.
Front Immunol
; 15: 1374293, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680489
7.
Development and Application of a High-Throughput Method for the Purification and Analysis of Surface Carbohydrates from Klebsiella pneumoniae.
Biology (Basel)
; 13(4)2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38666868
8.
Vaccines for a sustainable planet.
Sci Transl Med
; 15(685): eadf1093, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857432
9.
A next-generation GMMA-based vaccine candidate to fight shigellosis.
NPJ Vaccines
; 8(1): 130, 2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670042
10.
Characterization of Enzyme-Linked Immunosorbent Assay (ELISA) for Quantification of Antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-Antigens in Human Sera.
BioTech (Basel)
; 12(3)2023 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606441
11.
Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus.
Carbohydr Polym
; 311: 120736, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37028871
12.
Towards a Four-Component GMMA-Based Vaccine against Shigella.
Vaccines (Basel)
; 10(2)2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35214786
13.
A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development.
Hum Vaccin Immunother
; 18(6): 2136451, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495000
14.
Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal Salmonella.
Methods Protoc
; 5(6)2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36548142
15.
A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements.
PLoS Pathog
; 5(12): e1000710, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20041170
16.
GMMA-Based Vaccines: The Known and The Unknown.
Front Immunol
; 12: 715393, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413858
17.
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.
Vaccines (Basel)
; 9(1)2021 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33440898
18.
Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant.
Mol Cell Proteomics
; 7(3): 473-85, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17982123
19.
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
Lancet Infect Dis
; 20(1): 80-91, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630990
20.
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
Vaccine
; 37(35): 4823-4829, 2019 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362819